Navigation Links
Delcath Systems Receives Refusal to File Letter From FDA
Date:2/22/2011

NEW YORK, Feb. 22, 2011 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) announced today that the Company has received a "refusal to file" letter from the U.S. Food & Drug Administration (FDA) for the New Drug Application (NDA) for its proprietary chemosaturation system used in the treatment of patients with metastatic melanoma in the liver through the percutaneous intra-arterial administration of melphalan hydrochloride.  Delcath expects to submit a formal meeting request to the FDA this week and intends to meet with the FDA at the earliest opportunity to discuss the issues raised and to confirm our understanding of the remedies required for the filing to be accepted.  Based on management's current understanding of the information in the FDA's letter, the Company intends to resubmit the NDA by September 30, 2011.  

In accordance with application regulations, the FDA has the ability to formally file or refuse to file an application within 60 days of the completion of the submission, which occurred on December 22, 2010.  Neither the acceptance nor non-acceptance of the NDA filing is a determination of the approvability of the chemosaturation system.

"The FDA's letter requested information involving manufacturing plant inspection timing, product and sterilization validations and additional safety information that we already planned on filing with our 120 day safety update in April, as well as additional statistical analysis clarification," said Eamonn P. Hobbs, CEO & President of Delcath Systems. "We believe that we will be able to provide the requested information in an updated application and we expect to resubmit the NDA by the end of the third quarter of this year.  In the meantime, the CE Mark Technical File review process for marketing approval of the Hepatic ChemoSAT™ Delivery System continues on schedule.  Our expec
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Delcath Achieves ISO 13485 Certification
2. Delcath Completes New Drug Application Submission to the FDA for the Chemosaturation Delivery System
3. Delcath Systems Announces Third Quarter Progress Report Conference Call
4. Delcath Strengthens Research and Development Team with Key Appointments
5. Delcath Signs Agreement With Synerx and Mylans Bioniche Teoranta for Melphalan Supply
6. Delcath to Present at the William Blair Emerging Growth Stock Conference
7. Delcath to Present at the JMP Securities Healthcare Conference
8. Delcath Systems Announces Completion of Common Stock Offering
9. Delcath to Present at the 30th Annual Canaccord Global Growth Conference
10. Delcath to Present at the 2010 Wedbush Securities Life Sciences Best Ideas Management Access Conference
11. Delcath Systems Announces Second Quarter Progress Report Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ... (OFT) approval condition to the announced tender offer for all of ... As a result of the waiver, the transaction is no longer ... offer on January 24, 2014 following the currently scheduled expiration time, ...
(Date:1/15/2014)... 2014 BreedIT Corp (OTC: BRDT), through ... of highly sophisticated agro-breeding solutions for plant breeders and ... Company,s board of directors appointed chemistry and pharmaceutical industry ... member of the board. From 1975 to ...
(Date:1/15/2014)... PALM BEACH GARDENS, Fla. , Jan. 15, 2014  In an ... C. difficile and TB in ambulances and other transport vehicles, an ... being used by rescue personnel for the first time. ... coming in contact with these deadly pathogens, West Palm ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Superbugs No Longer Ride In Rescue Vehicles 2
... Pharmaceutical Inc. (Nasdaq: BMRN ) today ... BioMarin, will host a conference call and webcast ... to discuss fourth quarter and full year 2010 ... Number:  617.213.8848Participant Code: 90635895Replay Dial-in Number: 888.286.8010Replay International ...
... Matrixx Initiatives, Inc. (Nasdaq: MTXX ... company that develops and markets Zicam® products, today ... for in the previously announced merger agreement, dated ... Matrixx, Wonder Holdings, Inc. ("Wonder") and Wonder Holdings ...
Cached Medicine Technology:BioMarin to Host Fourth Quarter and Full Year 2010 Financial Results 2Matrixx Initiatives, Inc. Announces End of 'Go-Shop' Period 2Matrixx Initiatives, Inc. Announces End of 'Go-Shop' Period 3
(Date:4/17/2014)... Doctors who treat patients with a severe ... face an agonizing treatment decision. , The drug ... help relieve shortness of breath. But some patients ... cause potentially fatal complications following transplantation. , "It,s ... medical director of Loyola University Medical Center,s LAM ...
(Date:4/17/2014)... NEW YORK, NY (April 16, 2014) The cause ... but a new study proposes that neurons may be ... own immune system, similar to the way autoimmune diseases ... attack the body,s cells. The study was published April ... is a new, and likely controversial, idea in Parkinson,s ...
(Date:4/17/2014)... By discovering a new mechanism that allows blood to ... UC Irvine and the Salk Institute have opened the ... stroke-induced brain damage. , A complex and devastating neurological ... primary reason for disability in the U.S. The blood-brain ... blood-borne material into the brain, causing the permanent deficits ...
(Date:4/17/2014)... NEW YORK April 17, 2014 EcoHealth Alliance, ... public health issues, published a comprehensive review today examining ... and Marburg virus. The review calls for improved global ... such as the recent outbreak of Ebola in West ... in the countries of Guinea and Liberia. According ...
(Date:4/17/2014)... online has the potential to ward off depression among ... research published online in The Journals of ... . In the article " Internet Use and Depression ... Longitudinal Analysis ," the authors report that Internet use ... percent among their study sample. , Late-life depression ...
Breaking Medicine News(10 mins):Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Is Parkinson's an autoimmune disease? 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Internet use may cut retirees' depression 2
... According to a survey done by the U.S. government it was ... among the America's elderly population//. It is said that adults aged ... estimated that the number of people addicted to drug would double ... generation is addicted to drugs due to problems such as pain, ...
... Drug addiction is becoming a significant public health probelm ... that the number of individuals with drug addiction// problems ... of 2020. ,Nearly 2.5 million Americans have ... 1999. The increasing inclination of elders to take drugs ...
... collaborate to prove through clinical trials the efficacy of ... known to cure but for which there is no ... collaboration has been approved by the board members and ... to the government for seeking funding," said Ranjit Roy ...
... has confirmed five more bird flu related deaths in Indonesia, ... team has further been sent to the northern Sumatra region, ... same family) had lived. The fifth victim was a 38-year-old ... and meat. ,,It is further suspected that eight ...
... helps to protect the lungs of premature infants from ... McMaster University researchers have reported// an early finding in ... caffeine therapy for the treatment of apnoea of prematurity. ... preterm infants, because the lungs are underdeveloped and the ...
... will not be allowed to make tall claims on their ... EU lawmakers have clamped down on misleading claims or health ... to set a common standard for vitamins, minerals and food ... manufacturers who are not able to justify their claims will ...
Cached Medicine News:Health News:Indian And Chinese Doctors Join Together To Prove The Efficacy Of Herbal Drugs 2Health News:Indian And Chinese Doctors Join Together To Prove The Efficacy Of Herbal Drugs 3Health News:Caffeine Therapy May Help Protect Lungs Of Premature Babies 2
... many as three tests confirmed Sterillium Rub's ... according to FDA (Time Kill study and ... Drug Products) and one European test - ... the relevant international efficacy specifications. Sterillium Rub ...
HIBICLENS' non-drying, low skin irritation potential promotes compliance with the frequent hand washing associated with today's clinical protocols....
... All of The Scrub Care® ... are formulated for the ultimate in ... harmful bacteria while keeping skin healthy ... use. This solutions do not contain ...
Exidine® 2% CHG Brushless Surgical Scrub offers exceptional persistence and broad-spectrum antimicrobial activity....
Medicine Products: